Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Ascelia Pharma AB

Closing information (x1000 DKK)

Closing information 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 2,650 Less Arrow 1,464 More Arrow 13,429
Earnings before taxes -88,979 Less Arrow -94,180 More Arrow -73,929
EBITDA -97,536 Less Arrow -99,557
Total assets 146,055 More Arrow 242,493 Less Arrow 189,273
Current assets 107,498 More Arrow 199,678 Less Arrow 145,508
Current liabilities 25,070 Less Arrow 18,255 Less Arrow 13,609
Equity capital 120,856 More Arrow 223,836 Less Arrow 174,955
- share capital 23,302 More Arrow 25,141 Less Arrow 17,409
Employees (average) 22 Less Arrow 20 Less Arrow 11

Financial ratios

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Solvency 82.7% More Arrow 92.3% More Arrow 92.4%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -59.1% More Arrow -38.2% More Arrow -32.0%
Current ratio 428.8% More Arrow 1093.8% Less Arrow 1069.2%
Return on equity (ROE) -73.6% More Arrow -42.1% Less Arrow -42.3%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 2 More Arrow 9 Less Arrow 4
Chg. No. of employees % 10% More Arrow 82% Less Arrow 57%

Total value of public sale

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.